Alembic Pharmaceuticals jumps on receiving USFDA approval for Amantadine Hydrochloride Capsules

22 Jun 2017 Evaluate

Alembic Pharmaceuticals is currently trading at Rs. 541.00, up by 9.10 points or 1.71% from its previous closing of Rs. 531.90 on the BSE.

The scrip opened at Rs. 540.00 and has touched a high and low of Rs. 543.80 and Rs. 538.05 respectively. So far 1716 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 709.30 on 23-Mar-2017 and a 52 week low of Rs. 517.00 on 15-Jun-2017.

Last one week high and low of the scrip stood at Rs. 545.00 and Rs. 518.80 respectively. The current market cap of the company is Rs. 10180.80 crore.

The promoters holding in the company stood at 72.68%, while Institutions and Non-Institutions held 13.74% and 13.58% respectively.

Alembic Pharmaceuticals has received approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Amantadine Hydrochloride Capsules, USP, 100mg. The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD) Symmetrel Capsules, 100mg, of Endo Pharmaceuticals Inc. Amantadine Hydrochloride Capsules have an estimated market size of $37 million for twelve months ending December 2016, according to IMS.

Amantadine Hydrochloride Capsules, USP are indicated for the prophylaxis and treatment of signs and symptoms of infection caused by various strains of influenza A virus. Amantadine Hydrochloride Capsules, USP are also indicated in the treatment of parkinsonism and drug-induced extrapyramidal reactions. Alembic now has a total of 58 ANDA approvals (52 final approvals and 6 tentative approvals) from USFDA.

Alembic Pharmaceuticals, a vertically integrated research and development pharmaceutical company, has been at the forefront of Healthcare since 1907. The company manufactures and markets generic pharmaceuticals products all over the world.

Alembic Pharma Share Price

852.30 -4.95 (-0.58%)
26-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.20
Dr. Reddys Lab 1269.05
Cipla 1505.05
Zydus Lifesciences 911.50
Lupin 2112.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×